Organization
Froedtert & Medical College of Wisconsin Cancer Center
1 abstract
Abstract
Exposure-response analyses for optimal therapeutic dose selection of ABBV-383 in patients with relapsed/refractory multiple myeloma (RRMM).Org: Levine Cancer Institute, Atrium Health, Wake Forest University School of Medicine, Froedtert & Medical College of Wisconsin Cancer Center,